For this purpose, a panel of 10 CAR T cells targeting BCMA, CD38, and CD138 with varying affinities were evaluated for their cytotoxic efficacy against MM cells in the presence of BM-MSCs [26]. The gene discussed is CD38; the disease is Miyoshi myopathy.